Hsbc Holdings PLC lifted its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 635.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 218,287 shares of the company’s stock after purchasing an additional 188,587 shares during the quarter. Hsbc Holdings PLC’s holdings in Avantor were worth $2,514,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Wellington Management Group LLP acquired a new position in shares of Avantor in the 4th quarter valued at approximately $268,584,000. London Co. of Virginia acquired a new position in shares of Avantor in the third quarter valued at approximately $159,669,000. Morgan Stanley increased its position in shares of Avantor by 179.4% during the fourth quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock worth $200,188,000 after acquiring an additional 11,216,565 shares in the last quarter. Norges Bank acquired a new stake in shares of Avantor during the fourth quarter worth $73,322,000. Finally, Bank of America Corp DE raised its holdings in shares of Avantor by 122.0% during the second quarter. Bank of America Corp DE now owns 7,495,095 shares of the company’s stock worth $100,884,000 after acquiring an additional 4,119,522 shares during the period. Institutional investors own 95.08% of the company’s stock.
Insiders Place Their Bets
In other news, Director Gregory T. Lucier purchased 10,000 shares of the business’s stock in a transaction on Friday, May 8th. The stock was purchased at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the completion of the purchase, the director directly owned 60,000 shares in the company, valued at $499,200. The trade was a 20.00% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Simon Dingemans acquired 25,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The stock was purchased at an average cost of $8.14 per share, with a total value of $203,500.00. Following the transaction, the director owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.28% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on AVTR
Avantor Stock Down 1.1%
NYSE:AVTR opened at $10.39 on Friday. The firm has a market capitalization of $7.10 billion, a price-to-earnings ratio of -12.83, a price-to-earnings-growth ratio of 6.09 and a beta of 0.94. Avantor, Inc. has a twelve month low of $7.26 and a twelve month high of $15.93. The stock’s 50 day moving average price is $9.11 and its two-hundred day moving average price is $9.43. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.
Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The business’s revenue was up .0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.23 EPS. Equities research analysts expect that Avantor, Inc. will post 0.79 earnings per share for the current fiscal year.
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Stories
- Five stocks we like better than Avantor
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
- MarketBeat Week in Review – 07/06 – 07/10
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
